Status:
COMPLETED
Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Coronary Artery Calcification
Cardiac Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiac computed tomography (CCT) is one of the standard non-invasive imaging techniques allowing imaging of the heart and coronary arteries with a high temporal and spatial resolution. The high sensi...
Detailed Description
Cardiac diseases still are the leading cause of death in the western world. Besides the high mortality of the cardiac disease itself, recent studies have shown an increasing evidence of the prognostic...
Eligibility Criteria
Inclusion
- Patients referred for CCTA;
- Age \> 18 years;
- Informed consent obtained.
Exclusion
- Inability to perform a breath hold for the expected scan time;
- Hemodynamic instability;
- Pregnancy;
- Renal insufficiency (defined as glomerular filtration rate (GFR) \< 30 mL/min);
- Iodine allergy;
- Age \< 18 years;
- Absence of informed consent.
Key Trial Info
Start Date :
April 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2018
Estimated Enrollment :
327 Patients enrolled
Trial Details
Trial ID
NCT03292354
Start Date
April 11 2017
End Date
September 14 2018
Last Update
March 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Zuid-Limburg, Netherlands, 6202AZ